GSK To Supply Combivir For NIH Trial Following Letter From Rep. Waxman
Executive Summary
GlaxoSmithKline will provide Combivir at a discounted rate for a clinical trial on HIV treatment in developing countries following a letter from Rep. Henry Waxman (D-Calif.) admonishing the company for withdrawing from the study
You may also be interested in...
IoM AIDS Report Urges International Treatment Quality Assurance Standard
The Institute of Medicine recommends the creation of international quality assurance systems to ensure the quality of AIDS treatments for the developing world
IoM AIDS Report Urges International Treatment Quality Assurance Standard
The Institute of Medicine recommends the creation of international quality assurance systems to ensure the quality of AIDS treatments for the developing world
GSK Faces New York Suit Over Paxil: Publish Or Punish?
GlaxoSmithKline's failure to publish pediatric safety study results for its antidepressant Paxil (paroxetine) is one basis of fraud allegations lodged against the company by New York Attorney General Eliot Spitzer